Santen Pharmaceutical to Buy Novagali Pharma for $136 Million
9/28/2011 6:50:17 AM
More...
|
Biotech Novagali Pharma in Takeover Talks, Mulls IPO
4/14/2010 7:06:57 AM
More...
|
Novagali Pharma Announces FDA Clearance of IND for Phase III of Catioprost(R), its Cationic Emulsion of Latanoprost in Patients With Glaucoma
5/5/2009 8:39:26 AM
More...
|
Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
4/15/2009 10:22:17 AM
More...
|
Novagali Pharma Presents Results of its Innovative Latanoprost Formulation for Glaucoma
2/27/2009 9:54:31 AM
More...
|
Novagali Pharma Completes a EUR15 Million Fund Raising
9/26/2008 6:25:20 AM
More...
|
Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
4/24/2008 6:36:47 AM
More...
|
Novagali Pharma Announces the Launch of Cationorm(R) The Innovative Cationic Emulsion for the Treatment of Dry Eye Symptoms
4/10/2008 7:04:52 AM
More...
|
Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia(R) in Children Suffering From Vernal Keratoconjunctivitis
6/25/2007 12:27:38 PM
More...
|
Novagali Pharma Strengthens its Executive Management
6/20/2007 12:05:25 PM
More...
|
|